ProCell Therapies
ProCell Therapies develops and sells automated microchanneling devices paired with proprietary PRO and MD aftercare serums to a global network of 12,000+ certified skincare practitioners, supporting anti-aging, pigmentation, scarring, and hair-restoration treatments for end consumers.
- Company typePrivate
- Founded2014
- HeadquartersAustin, United States
- Headcount11–50
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What ProCell Therapies does
ProCell Therapies is a US-based, privately held medical-device and biotech company founded in 2014 by dermatologist Mitchell Schwartz, MD, that markets an automated microchanneling platform positioned as an evolution of manual microneedling. The technology creates controlled micro-injuries that trigger natural skin regeneration, paired with proprietary aftercare serums (PRO and MD lines: Cellular Renewal Serum, Healing Accelerator, plus treatment vials and hydrating masks) that deliver growth factors and cytokines to enhance post-procedure healing. Devices are sold exclusively to licensed practitioners who complete a certification/training program, while the company also operates a direct-to-consumer e-commerce storefront for serums and masks and maintains a consumer-facing practitioner locator driving demand to its provider network. The company supports a global base of 12,116+ certified practitioners across 41 countries and reports cumulative use of 1.5 million+ treatments, monetized across three streams: device sales (to verified practitioners, schools, franchises, and distributors), recurring serum and aftercare product sales (PRO and MD tiers, plus hair-restoration vials), and practitioner training/workshops. The business is founder-led, bootstrapped to the extent disclosed (no funding rounds, investors, or M&A in the source data), and operates with 11-50 employees from Austin, Texas.
ProCell Therapies firmographics
Firmographics- Name
- ProCell Therapies
- Legal name
- Procell Therapies
- Website
- https://procelltherapies.com
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- ProCell Therapies develops and sells automated microchanneling devices paired with proprietary PRO and MD aftercare serums to a global network of 12,000+ certified skincare practitioners, supporting anti-aging, pigmentation, scarring, and hair-restoration treatments for end consumers.
- Ownership category
- akta.pro rank
ProCell Therapies industry classification
Industry- Product category
- Medical Aesthetics Devices
- NAICS
- Medical Equipment and Supplies Manufacturing (3391), Biological Product (except Diagnostic) Manufacturing (325414)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Professional/Backbar Skincare (Esthetician & Spa Use) (CRABAAAK)
- akta.pro secondary industries
- Dermocosmetics & Medical-Grade Skincare (CRABAAAF), Treatment Skincare (Serums, Actives, Acne & Anti-aging) (CRABAAAB)
Keywords
Where ProCell Therapies is headquartered
LocationHeadquarters
- HQ city
- Austin
- HQ country
- United States
- HQ region
- North America
Markets served
ProCell Therapies business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Operations
Revenue model
- Serum and Aftercare Product Sales: Sale of proprietary aftercare serums including Cellular Renewal Serum and Healing Accelerator in PRO and MD formulations, sold directly to practitioners and consumers through e-commerce. Products include trial sets and individual vials for treatment use.
- Microchanneling Device Sales: Sale of microchanneling devices to licensed practitioners, schools, franchises, and distributors. Devices are sold to certified/verified practitioners who complete required training.
- Practitioner Training and Workshops: Revenue from workshops and training programs for practitioners seeking to offer Procell Microchanneling treatments, including certification and ongoing education.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | PRO Aftercare Line - Entry-level professional-grade serums |
| Unit Pricing | Pay-as-you-go | MD Aftercare Line - Maximum-strength professional formulations |
| Unit Pricing | Pay-as-you-go | Treatment Vials - Serum treatments for practitioner use |
| Unit Pricing | Pay-as-you-go | Hydrating Face Masks |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels4 records
ProCell Therapies product offering
Product offeringCore offering
ProCell Therapies designs, manufactures, and sells automated microchanneling devices and proprietary growth factor / cytokine-rich aftercare serums used by licensed skincare practitioners to deliver non-invasive skin rejuvenation treatments (anti-aging, wrinkle reduction, pigmentation, scarring, and hair regrowth). The company also operates a global certified practitioner network and runs training/workshops for practitioners adopting its technology.
Product overview
Procell Therapies offers a dual-tier product portfolio built around its proprietary Microchanneling technology, which it positions as microneedling evolved. The product ecosystem consists of two distinct lines: the PRO line (designed for consumers and licensed practitioners) and the MD line (medical-grade products for clinical/professional use). The portfolio includes serum treatment vials used during microchanneling procedures (Hair Serum Treatment Vials MCS, MD Serum Treatment Vials MCS, PRO Serum Treatment Vials MCS), two-step aftercare systems (Cellular Renewal Serum and Healing Accelerator) sold as both individual products and trial sets, and hydrating face masks. The company also provides microchanneling devices sold to licensed practitioners. Founded in 2014 by Dr. Mitchell Schwartz with over 30 years of dermatology experience, Procell Therapies has performed over 1.5 million treatments across 41 countries. The science behind the products is supported by peer-reviewed research on growth factors, cytokines, mesenchymal stem cells, and wound healing mechanisms.
Differentiator
Problem solved
Functional benefit
Products and services
- ProCell Microchanneling Devices Automated microchanneling devices that create controlled micro-injuries in the skin to stimulate natural collagen, elastin, and wound-healing responses; sold exclusively to licensed and certified practitioners who have completed required training.
- PRO Aftercare Step 1 - Cellular Renewal Serum
Quantifiable outcome
- 1,505,911 treatments performed globally
- +1 more outcomes
Companies that use ProCell Therapies
Customer profileSegments3 records
Ideal customer profiles3 records
ProCell Therapies technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
ProCell Therapies partnerships and signals
Strategic signalScale indicators4 records
Recent moves6 records
Expansion highlights5 records
ProCell Therapies competitors and assessment
Company assessmentDirect peers
- SkinPen (Crown Aesthetics): SkinPen is a leading FDA-cleared microneedling device sold to licensed practitioners and med-spas, the closest direct competitor to Procell's microchanneling device-plus-serum system. Both compete for the same practitioner accounts with a comparable device-plus-topical regimen.
- Dermapen World: Dermapen sells automated microneedling pens and proprietary treatment serums to skincare professionals worldwide, mirroring Procell's two-sided model of selling devices to practitioners paired with branded consumables.
- Eclipse Aesthetics: Eclipse markets the Dermaroller line of microneedling devices and accompanying topical products to practitioners and med-spas, directly competing with Procell in professional microchanneling and treatment serum channels.
- Environ Skin Care: Environ is a professional skincare brand built around vitamin A and growth-factor science, distributed through a global network of trained skincare professionals and institutions, mirroring Procell's practitioner certification and channel-partner model.
- PCA Skin: PCA Skin is a professional skincare brand sold primarily through licensed estheticians and physicians for in-office treatment and home regimens. It targets the same licensed-practitioner channel and end-consumer anti-aging use cases as Procell.
- iS Clinical (Innovative Skincare): iS Clinical develops and sells cosmeceutical and post-procedure skincare to physicians, spas, and licensed professionals worldwide. It competes head-to-head with Procell in supplying serums and aftercare products used alongside in-office microneedling and rejuvenation treatments.
Broad incumbents
- SkinMedica (AbbVie Allergan Aesthetics): SkinMedica is a physician-dispensed professional skincare brand built around growth factor science (TNS), sold through dermatology and med-spa channels like Procell's MD line. It is a broader incumbent with deeper R&D and institutional backing.
- Alastin Skincare (Galderma): Alastin is a fast-growing physician-dispensed skincare brand grounded in tripeptide and growth-factor science, sold through dermatology and aesthetics practices. Its procedural skincare pairing strategy directly parallels Procell's approach of supplying serums alongside in-office treatments.
- SkinCeuticals (L'Oréal): SkinCeuticals sells advanced skincare backed by clinical science through dermatologists, plastic surgeons, and med-spas. It is a much larger incumbent competing for the same professional-dispensed skincare shelf space as Procell's PRO and MD lines.
- Cynosure (El.En. S.p.A.): Cynosure is a leading global aesthetic device platform offering energy-based systems and consumables for skin rejuvenation to med-spas and practices. It is a broader incumbent with the capital and distribution to bundle competing microneedling-like modalities against Procell's device franchise.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
ProCell Therapies social profiles
Digital presenceProCell Therapies financial estimates
Financial estimateRevenue estimate
Valuation estimate
ProCell Therapies leadership team
Management profileNumber of profiles
Profiles1 record
ProCell Therapies funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ProCell Therapies M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ProCell Therapies
What does ProCell Therapies do?
ProCell Therapies designs, manufactures, and sells automated microchanneling devices and proprietary growth factor / cytokine-rich aftercare serums used by licensed skincare practitioners to deliver non-invasive skin rejuvenation treatments (anti-aging, wrinkle reduction, pigmentation, scarring, and hair regrowth). The company also operates a global certified practitioner network and runs training/workshops for practitioners adopting its technology.
Is ProCell Therapies a public or private company?
ProCell Therapies is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was ProCell Therapies founded?
ProCell Therapies was founded in 2014. It employs 11 to 50 people.
Where is ProCell Therapies based?
ProCell Therapies is headquartered in Austin, United States, in the North America region.
How does ProCell Therapies make money?
Three revenue lines are on record. Serum and Aftercare Product Sales are the primary driver. The others are microchanneling Device Sales and practitioner Training and Workshops.
Who are ProCell Therapies's main competitors?
Direct peers on record are SkinPen (Crown Aesthetics), Dermapen World, Eclipse Aesthetics, Environ Skin Care, PCA Skin and iS Clinical (Innovative Skincare). Broad incumbents are SkinMedica (AbbVie Allergan Aesthetics), Alastin Skincare (Galderma), SkinCeuticals (L'Oréal) and Cynosure (El.En. S.p.A.).
Does ProCell Therapies have an API?
No public API is recorded for ProCell Therapies.
What industry is ProCell Therapies in?
ProCell Therapies's product category is Medical Aesthetics Devices. Its primary akta.pro industry code is CRABAAAK, Professional/Backbar Skincare (Esthetician & Spa Use), with a secondary code of CRABAAAF, Dermocosmetics & Medical-Grade Skincare. Its NAICS code is 3391 and its SIC code is 3841.